Amlodipine besylate; hydrochlorothiazide; valsartan
is the generic ingredient in one branded drug marketed by Novartis
and is included in one NDA. There are three patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.
This ingredient has thirty-four patent family members
in twenty-nine countries.
There are forty-six drug master file entries
for amlodipine besylate; hydrochlorothiazide; valsartan. Four suppliers
are listed for this compound.